Text Size
- News Releases
- What's New
- 25 Nov
- Anti-Cancer Agent Herceptin Approved for Additional Indication of Salivary Gland Cancer
- 18 Nov
- Personnel Changes
- 17 Nov
- Atea Announces Update on Collaboration with Roche for AT-527
- 16 Nov
- Chugai Obtains Regulatory Approval for FoundationOne CDx Cancer Genomic Profile to Identify TMB-High Tumors
- 16 Nov
- Chugai Hosted Discussion Series to Drive Quality Cancer Care in Developing Countries in Asia in Partnership with City Cancer Challenge
Video Introduction of CHUGAI- Share this site
